← Eichor
Study identifier: NCT06547463 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Nasal Airflow on Sleep in Tracheotomized Patients

Condition: Patients With Prolonged Weaning  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseN/A
Planned participants24
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The passage of air through the nasal cavities generates rhythmic oscillations transmitted by the olfactory bulb to the brain, which induces cerebral activation in functional brain areas and is associated with better cognitive performance compared to oral breathing. Consequently, the abolition of nasal ventilation - intrinsic in tracheotomized and ventilated patients - could have deleterious effects on brain activity. Besides the loss of olfaction, the abolition of nasal ventilation could affect brain activity and sleep. The hypothesis of the present study is that the restoration of nasal stimulation by the passage of humidified nasal airflow in tracheotomized and ventilated patients improves sleep quality, notably with a greater proportion of time spent in REM sleep.

This description comes directly from the study's public registry record.

Talk to the study team

Martin Dres, MD, PhD  ·  0142167809  ·  martin.dres@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Pitié Salpétrière HOSPITALParis, Paris, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06547463